AI Analysis AI Analysis of DXCM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DXCM to Watchlist?
Some Reasons Why To Add DXCM:
  • Excellent financial health (Piotroski 8/9)
  • Healthy interest coverage ratio of 61.9x
  • Low bankruptcy risk (Altman Z-Score: 6.83)
PDF

DexCom stock price up 1.64% on Tuesday
(Updated on Jul 07, 2026)

Buy candidate since Jul 06, 2026 Gain 1.64%

The DexCom stock price gained 1.64% on the last trading day (Tuesday, 7th Jul 2026), rising from $72.38 to $73.57. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.64% from a day low at $72.07 to a day high of $73.97. The price has risen in 6 of the last 10 days and is up by 6.52% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 977 thousand more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $409.72 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 20.20% during the next 3 months and, with a 90% probability hold a price between $79.04 and $98.89 at the end of this 3-month period.

DXCM Signals & Forecast

The DexCom stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $70.50 and $71.58. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 09, 2026, and so far it has fallen -5.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for DexCom stock

DexCom finds support from accumulated volume at $71.44 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.90 between high and low, or 2.64%. For the last week, the stock has had daily average volatility of 3.71%.

Our recommended stop-loss: $70.42 (-4.28%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 18 days ago.)

Trading Expectations (DXCM) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect DexCom to open at $73.20, and during the day (based on 14 day Average True Range), to move between $72.30 and $74.84, which gives a possible trading interval of +/-$2.54 (+/-3.52%) up or down from last closing price. If DexCom takes out the full calculated possible swing range there will be an estimated 3.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $73.74 (0.23%) than the support at $71.44 (2.90%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is DexCom stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for DexCom stock to perform well in the short-term.

Current score: 1.262 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $73.20 ( 0.498%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DXCM Performance

Trading levels for DXCM

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 75.10 2.08%
R2 74.38 1.10%
R1 73.93 0.488%
Price 73.57
S1 72.48 -1.48%
S2 72.03 -2.09%
S3 71.30 -3.08%

Accumulated Volume Support & Resistance Levels

Level Price
R3 76.62 4.15%
R2 74.87 1.77%
R1 73.74 0.231%
Price 73.57
S1 71.44 -2.90%
S2 66.95 -9.00%
S3 65.09 -11.53%

FAQ

What is the symbol for DexCom Stock and on which exchange is it traded?
The symbol for DexCom is DXCM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell DexCom Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for DexCom stock to perform well in the short-term.

How to buy DexCom Stock?
DexCom Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy DexCom Stock.

What's the current price of DexCom Stock?
As of the end of day on the Jul 07, 2026, the price of an DexCom (DXCM) share was $73.57.

What is the 52-week high and low for DexCom Stock?
The 52-week high for DexCom Stock is $89.98 and the 52-week low is $54.11.

What is the market capitalization of DexCom Stock?
As of the Jul 07, 2026, the market capitalization of DexCom is 28.389B.

When is the next earnings date for DexCom?
The upcoming earnings date for DexCom is Jul 29, 2026.
Click to get the best stock tips daily for free!
ABOUT DEXCOM
DexCom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to i...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
16.27% Jun 29
OSIS
$218.29
0.197% Jun 26
NMRK
$15.02
4.19% Jun 24
X
XMAX
$8.34
4.56% Jun 24
TTEK
$28.04
10.31% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE